Debate over the need for Covid-19 booster shots is clouding the outlook for Moderna Inc’s high-flying shares after the US biotechnology company’s stock price soared as much as 360% this year, making it the best performer in the S&P 500. Investors yesterday were awaiting comments from a panel of outside experts, which is weighing whether to recommend if US regulators should approve Pfizer and partner BioNTech’s application for an extra round of shots for their vaccine. Moderna, whose vaccine is based on a similar messenger RNA (mRNA) technology, applied earlier this month to allow use of a booster dose, but that was not expected to be taken up in yesterday’s meeting. Moderna has benefited fr
Hence then, the article about moderna shares rally cools over booster doubts was published today ( ) and is available onGulf Times ( Qatar ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Moderna shares rally cools over ‘booster’ doubts )